Header Logo

Connection

NAVAL DAVER to Antibodies

Back to Details
This is a "connection" page, showing publications NAVAL DAVER has written about Antibodies.
NAVAL DAVER
Connection Strength
0.597
Antibodies
  1. A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia. Am J Hematol. 2021 05 01; 96(5):E175-E179.
    View in: PubMed
    Score: 0.597
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.